Mylan Recalls Carboplatin Injection Due to Particulate Matter
Mylan Institutional LLC recalls specific lots of Carboplatin Injection vials due to the presence of particulate matter. Check lot numbers and expiration dates.
Stop using this now
Presence of Particulate Matter
Contact the company
What happened, in plain English
Mylan Institutional LLC is recalling a specific quantity of Carboplatin Injection vials because they contain visible particulate matter. This Class I recall involves 4,445 vials distributed nationwide. The record does not specify the exact health consequences or the remedy for this recall. Read more at govinfonow.com/recall/44834-mylan-institutional-llc-recalls-carboplatin-injection-450-mg-45-ml.
Source Summary by GovInfoNow · govinfonow.com/recall/44834-mylan-institutional-llc-recalls-carboplatin-injection-450-mg-45-ml · Updated October 12, 2026 · FDA enforcement record: FDA #D-1331-2015
Cite this page
“Mylan Recalls Carboplatin Injection Due to Particulate Matter.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/44834-mylan-institutional-llc-recalls-carboplatin-injection-450-mg-45-ml. Based on FDA recall #D-1331-2015 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1331-2015%22&limit=1).
Why it’s dangerous
The presence of particulate matter in an injectable drug can pose serious health risks if the particles enter the bloodstream, potentially causing blockages or other complications. Because this is a Class I recall, it indicates a situation where use could lead to serious adverse health consequences or death.
Who’s affected
Patients receiving chemotherapy treatment who have been administered or may receive Carboplatin Injection manufactured by Mylan Institutional LLC. Healthcare providers handling these specific vials are also affected.
How to tell if you have this one
Look for CARBOplatin Injection 450 mg/45 mL (10 mg/mL) in a 100 mL Multi-Dose Vial. Check the NDC 67457-493-46, UPC 3 67457 49346 6, and Lot # 7801312 with an expiration date of 06/15.
- Brand
Mylan Institutional- Product
CARBOplatin Injection 450 mg/45 mL (10 mg/mL), 45 mL packaged in a 100 mL Multi-Dose Vial, Rx only, Manufactured for- Category
Drug
What to do — step by step
Check Inventory
Verify if you have vials matching NDC 67457-493-46, UPC 3 67457 49346 6, and Lot # 7801312.
Consult Healthcare Provider
Contact your doctor or pharmacist immediately to determine if you have received this recalled product.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 14 months after the firm started it.
- Firm started the recall
- FDA classified it Class I
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1331-2015 (March 18, 2015) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1331-2015 to see it in context.
- Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.